1-3 of 3
Irene Rodriguez-Sanchez
Close
Sort by
Journal Articles

Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion–associated myeloid neoplasm

Oriana Miltiadous, Kseniya Petrova-Drus, Shipra Kaicker, Susan Mathew, Michael Kluk, Julia T. Geyer, Irene Rodriguez-Sanchez, Nancy Bouvier, Giorgio Inghirami, Elliot Stieglitz, Nafa Khedoudja, Ryma Benayed, Michelle Richardson, Wade Anderson, Jamal Benhamida, Daoqi You, Dory Londono, Andrew L. Kung, Susan E. Prockop, Mikhail Roshal, Yanming Zhang, Neerav Shukla
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1137–1142.
https://doi.org/10.1182/bloodadvances.2021004966
Published: 2022
Includes: Supplemental data
Journal Articles

ETV6-FLT3– positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML

Clinical Trials & Observations
Barbara Spitzer, Filemon S. Dela Cruz, Glorymar D. Ibanez Sanchez, Yanming Zhang, Wenbin Xiao, Ryma Benayed, Alina Markova, M. Irene Rodriguez-Sanchez, Nancy Bouvier, Mikhail Roshal, Andrew L. Kung, Neerav Shukla
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1899–1902.
https://doi.org/10.1182/bloodadvances.2020003699
Published: 2021
Journal Articles

Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4 + immunity to mediate durable responses

Clinical Trials & Observations
Vanessa A. Fabrizio, M. Irene Rodriguez-Sanchez, Audrey Mauguen, Parastoo B. Dahi, Ekaterina Doubrovina, Richard J. O’Reilly, Susan E. Prockop
Journal: Blood Advances
Blood Adv (2021) 5 (2): 496–503.
https://doi.org/10.1182/bloodadvances.2020002735
Published: 2021